Further processing options
Sorafenib as bridging therapy in patients with intermediate hepatocellular carcinoma.
Saved in:
Journal Title: | Journal of Clinical Oncology |
---|---|
Authors and Corporations: | , , , , , , |
In: | Journal of Clinical Oncology, 30, 2012, 15_suppl, p. e14563-e14563 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Clinical Oncology (ASCO)
|
Subjects: |